Its role in the regulation of apoptosis, tumor angiogenesis and proliferation, as well as tumor cell invasion and metastasis indicates that this transcription factor may become a therapeutic target in the treatment of many human cancers, including melanoma, in which the levels of NF-κB is constitutively increased. The gene discussed is NFKB1; the disease is melanoma.